Bryant Woods Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,796
Closed -$207K 43
2023
Q2
$207K Sell
1,796
-121
-6% -$13.7K 0.15% 40
2023
Q1
$204K Buy
1,917
+10
+0.5% +$1.08K 0.16% 39
2022
Q4
$212K Buy
+1,907
New +$195K 0.18% 38
2022
Q3
Sell
-3,548
Closed -$324K 40
2022
Q2
$324K Buy
3,548
+19
+0.5% +$1.68K 0.31% 29
2022
Q1
$290K Buy
+3,529
New +$278K 0.23% 30

Other funds holding MRK

Bryant Woods Investment Advisors's MRK Position: Q3 2023 in Review

Bryant Woods Investment Advisors sold out of Merck (MRK) in Q3 2023, closing a stake of 1,796 shares — an estimated $207K sold.

Bryant Woods Investment Advisors first reported a position in MRK in Q1 2022 and held it in 5 quarters. The position peaked at $324K in Q2 2022. 3,214 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Bryant Woods Investment Advisors reported no remaining Merck position as of Q3 2023 after selling out during the quarter.
  • Bryant Woods Investment Advisors sold 1,796 Merck shares in Q3 2023, an estimated $207K.
  • Bryant Woods Investment Advisors first reported a position in Merck in Q1 2022 and held it in 5 quarters.
  • Bryant Woods Investment Advisors's Merck position peaked at $324K in Q2 2022.
  • 3,214 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Bryant Woods Investment Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.